Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2012166712) RATIONALLY-DESIGNED ANTI-MULLERIAN INHIBITING SUBSTANCE TYPE II RECEPTOR ANTIBODIES
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2012/166712 International Application No.: PCT/US2012/039831
Publication Date: 06.12.2012 International Filing Date: 29.05.2012
IPC:
A61K 39/395 (2006.01) ,A61P 35/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
395
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
Applicants:
FOX CHASE CANCER CENTER [US/US]; 333 Cottman Avenue Philadelphia, PA 19111, US (AllExceptUS)
ADAMS, Gregory, P. [US/US]; US (UsOnly)
SIMMONS, Heidi, H. [US/US]; US (UsOnly)
ROBINSON, Matthew, K. [US/US]; US (UsOnly)
DUNBRACK, Roland [US/US]; US (UsOnly)
LEHMANN, Andreas [US/US]; US (UsOnly)
Inventors:
ADAMS, Gregory, P.; US
SIMMONS, Heidi, H.; US
ROBINSON, Matthew, K.; US
DUNBRACK, Roland; US
LEHMANN, Andreas; US
Agent:
NETTER, Robert, C.; Dann, Dorfman, Herrell & Skillman 1601 Market Street, Suite 2400 Philadelphia, PA 19103-2307, US
Priority Data:
61/490,85227.05.2011US
Title (EN) RATIONALLY-DESIGNED ANTI-MULLERIAN INHIBITING SUBSTANCE TYPE II RECEPTOR ANTIBODIES
(FR) ANTICORPS DIRIGÉS CONTRE LE RÉCEPTEUR DE TYPE II D'UNE SUBSTANCE INHIBITRICE ANTI-MULLÉRIENNE CONÇUE DE FAÇON RATIONNELLE
Abstract:
(EN) Methods for generating hybrid antibodies are provided.
(FR) L'invention concerne des procédés de génération d'anticorps hybrides.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
CA2837472EP2714083US20140234213